December 19, 2012 | Scion Medical Limited Acquired B. Braun VascuFlex® Family of Products
December 19, 2012 – Newton, Massachusetts. Scion Medical Technologies, LLC, announced today that it parent company Scion Medical Limited has acquired a portfolio of peripheral interventional radiology products, including 36 global patents, from B. Braun. The portfolio consists of the VascuFlex® family of stent products currently marketed globally, a distal protection device and an embolization product in late stage development. The VascuFlex® product family has regulatory clearance and is currently marketed in over 20 countries in the European Union, Asia and South America countries.
“Scion is very pleased to add the B. Braun peripheral artery disease products to our growing global product portfolio focused on interventional diagnostics and therapeutic devices,” said Scion CEO Joseph Siletto. “Braun is a well-respected global company with a strong track record of producing innovative, quality products. We intend to continue to invest resources to develop and manufacture the acquired portfolio and to make them available to patients worldwide. We are also very pleased with the reception the products have had in the rapidly growing Chinese market which is a very important part of an integrated growth strategy of Scion Medical” The acquisition represents Scion’s fifth acquisition in the past 14 months.
About Scion Medical Technologies
Scion Medical Technologies is the US arm, and wholly owned subsidiary, of Scion Medical Limited. Scion Medical Limited is a fast growing China-based global medical device company with a focused strategy of acquiring, developing and growing medical device products for global distribution. The company is currently expanding rapidly in both the US and China. Since its inception in 2011, Scion has made five acquisitions and built an experienced cross-functional, global team with manufacturing, distribution and regulatory expertise in both countries.
About B. Braun – Sharing Expertise
B. Braun supplies the global healthcare market with products for anesthesia, intensive medicine, cardiology, extra corporeal blood treatment and surgery, as well as services for hospitals, general practitioners and the homecare sector. Through dialogue with those who are using B. Braun’s products, the company is continually gaining new knowledge which it incorporates into product development. In this way, the company contributes with innovative products and services towards optimizing working procedures in hospitals and medical practices all over the world and improving safety – for patients, doctors and nursing staff. With approx. 45,000 employees in more than 50 countries, B. Braun generated sales in 2011 of more than EUR 4.6 bn.